Bupropion Hydrochloride Tablet
Product Images NDC 69097-918

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 69097-918). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc.,, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 100 mg (Bupropionhydrochloridetab 100mg 30tabs)

This is a pharmaceutical information sheet for a drug called buPROPion HCI, containing 100 tablets with a usual dosage detailed in the package insert. It is a warning that the medicine should not be used in combination with Zyban or other medicines containing bupropion hydrochloride. It is advised for pharmacists to dispense the medication guide provided separately for each patient. It also includes the manufacturer's details and instructions for storage.*

FDA Label Image

75 mg Label (Bupropionhydrochloridetab 75mg 30tabs)

This is a medication for oral use, which contains 75mg of bupropion HCI, USP per film-coated tablet. The medication prohibits the use of Zyban or other drugs containing bupropion hydrochloride. The patient is advised to keep the medication away from children and store it in a tight, moisture-free container at 20-25°C. The package insert contains full prescribing information. The medicine comes in a 100 tablet pack, under lot number 218708, with an expiration date shown as Exp. The drug is manufactured by InvaGen Pharmaceuticals in Hauppauge, NY, under Cipla USA's supervision, and is available only through prescription.*

FDA Label Image

Structure (Bupropionhydrochloridetab Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.